Roche's rollout of thousands of Nvidia chips is the latest example of a pharmaceutical giant trying to use AI to discover and ...

Swiss pharma Roche is staying in lockstep with Eli Lilly, expanding its AI offerings and Nvidia partnership shortly after the ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

Scientists at the University of Cambridge have developed a new way to alter complex drug molecules using light rather than ...

Drug discovery has traditionally been a reductive process—narrowing down, filtering out, and optimizing within established ...

Targeted modulation of certain intracellular signaling proteins could represent an exciting new approach to drug development.

Researchers have applied AI and machine learning to every stage of the drug development process. This includes identifying targets in the body, screening potential candidates, designing drug molecules ...

Machine-learning drug development company Insitro has inked three agreements with Eli Lilly for new medicines for metabolic diseases. But the deal is a little different compared to many recent deals ...

In a recently published review, a research team led by MedUni Vienna has highlighted a promising new approach to drug ...

Andrew Pierce is the senior vice president of discovery and development at a company that claims to be “first end-to-end AI biotech,” but he admits he doesn’t know the first thing about artificial ...

Oxana Iliach is a Senior Director of Regulatory Strategy at Certara (PA, USA), a biotech company that offers comprehensive solutions for transforming and accelerating drug development. In her spare ...